섬망 치료에서 Aripiprazole과Haloperidol의 효과： 무작위 개방 연구

참고문헌 (29)

1. Steven CS, "Kaplan and Sadock comprehensive textbook of psychiatry 8th edition", pp.1054~1068 (2004)
2. Brown TM, "Delirium", 325(7365), pp.644~647 (2002)
3. Gaudreau JD, "Association between psychoactive medications and delirium in hospitalized patients: a critical review", 46, pp.302~316 (2005)
4. Tune L, "The role of antipsychotics in treating delirium", 4, pp.209~212 (2002)
5. Schwartz TL, "The role of atypical an-tipsychotics in the treatment of delirium", 43, pp.171~174 (2002)
6. Sipahimalani A, "Use of risperidone in de-lirium: case reports", 9, pp.105~107 (1997)
7. Breitbart W, "An open trial of olanzapine for the treatment of delirium in hospitaliz-ed cancer patients", 43, pp.175~182 (2002)
8. Torres R, "Use of quetiapine in delirium: case reports", 42, pp.347~349 (2001)
9. Young CC, "Intravenous ziprasidone for treat-ment of delirium in the intensive care unit", 101, pp.794~795 (2004)
10. Alao AO, "Ariprazole and Delirium", 18, pp.267~269 (2005)
11. Novi F, "Partial agonist actions of aripiprazole and the candidate an-tipsychotics S33592, bifeprunox, N-desmethylcloza-pine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: poten-tial role of heterodimer formation" (2007)
12. Wood M, "Aripiprazole acts as a selective dopamine D2 receptor partial agonist", 16, pp.771~775 (2007)
13. Baker RW, "A symptom rating scale for delirium", pp.89~97
14. Straker DA, "Ariprazole in the Treatment of Delirium", 47, pp.385~391 (2006)
15. American Psychiatric Association, "Diagnostic and sta-tistical manual of mental disorders, text revision, DSM-IV-TR" (2000), Washington, DC: American Psychiatric Association
16. Lee Y, "Standardization of the Korean Version of Delirium Rating Scale", 9, pp.181~190 (2003)
17. Mittal D, "Risperidone in the treatment of delirium: results from a prospective open-label trial", 65, pp.662~667 (2004)
18. Mayo-Smith MF, "Management of alcohol withdrawal delirium. An evidence-based practice guide-line", 164, pp.1405~1412 (2004)
19. Le Y, "Validity and reliability of the Korean version of Delirium Rating Scale-R-98", pp.9~11 (2004), Seoul: WFSBP
20. Park JH, "Modification of the mini-mental state examination for use with the elderly in a non-western society; Part II", pp.875~82
21. Guy W. Clinical Global Impresion(CGI), "Handbook of Psychiatric Measures", pp.100~102 (2000), Washington, DC: American Psychiatric Asociation
22. Chouinard G, "Manual for the Extrapy-ramidal Symptom Rating Scale(ESRS)", 76, pp.247~265 (2005)
23. Woods SW, "Chlorpromazine equivalent doses for the newer atypical antipsychotics", 64, pp.663~667 (2003)
24. Bilder RM, "Neurocognitive effects of clo-zapine and haloperidol in patients with chronic schizophrenia or schizoafective disorder", 159, pp.1018~1028 (2002)
25. Swainstonn Harison T, "Ariprazole : a re-view of its use in schizophrenia and schizoaffective disorder", 64, pp.1715~1736 (2004)
26. Swainstonn Harrison T, "Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder", 64, pp.1715~1736 (2004)
27. van der Mast RC, "Pathophysiology of delirium", 11, pp.138~145 (1998)
28. Inouye SK, "Predisposing and precipitating factors for delirium in hospitalized older patients", 10, pp.393~400 (1999)
29. Jeste DV, "Conventional vs. newer antipsychotics in elderly patients", 7, pp.70~76 (1999)

관련 논문AI추천